1. Alterations in regulators of the extracellular matrix in non-Hodgkin lymphomas.
- Author
-
Negaard HF, Svennevig K, Kolset SO, Iversen N, Lothe IM, Østenstad B, Sandset PM, and Iversen PO
- Subjects
- Adult, Aged, Aged, 80 and over, Extracellular Matrix metabolism, Female, Humans, Lymphoma, Non-Hodgkin blood, Lymphoma, Non-Hodgkin genetics, Male, Matrix Metalloproteinase 2 blood, Matrix Metalloproteinase 2 genetics, Matrix Metalloproteinase 2 metabolism, Matrix Metalloproteinase 9 blood, Matrix Metalloproteinase 9 genetics, Matrix Metalloproteinase 9 metabolism, Matrix Metalloproteinases genetics, Matrix Metalloproteinases metabolism, Middle Aged, Syndecan-1 blood, Syndecan-1 genetics, Syndecan-1 metabolism, Tissue Inhibitor of Metalloproteinase-1 blood, Tissue Inhibitor of Metalloproteinase-1 genetics, Tissue Inhibitor of Metalloproteinase-1 metabolism, Tissue Inhibitor of Metalloproteinase-2 blood, Tissue Inhibitor of Metalloproteinase-2 genetics, Tissue Inhibitor of Metalloproteinase-2 metabolism, Tissue Inhibitor of Metalloproteinases genetics, Tissue Inhibitor of Metalloproteinases metabolism, Treatment Outcome, Extracellular Matrix drug effects, Lymphoma, Non-Hodgkin drug therapy, Matrix Metalloproteinases blood, Tissue Inhibitor of Metalloproteinases blood
- Abstract
Bone marrow angiogenesis is increased in non-Hodgkin lymphomas (NHL). Compounds affecting extracellular matrix (ECM) may modify angiogenesis. Here we investigated ECM regulators in 48 unselected NHL patients compared with 35 controls. Untreated patients had elevated (P < 0.05) serum matrix metalloproteinase (MMP) 9 and tissue inhibitor of metalloproteinase (TIMP) 1, while MMP-2, TIMP-2 and syndecan-1 were not significantly different from controls. MMP-9 mRNA was significantly up-regulated in blood mononuclear cells, while mRNA expressions of the other ECM regulators were unaltered. We found strong correlations between mRNA expressions of both vascular endothelial growth factor and fibroblast growth factor 2, and MMP-9, TIMP-1 and TIMP-2. After therapy, serum MMP-2 increased while MMP-9 decreased (P < 0.05), the others being unchanged. Several compounds affecting ECM may be involved in angiogenic activity in NHL.
- Published
- 2009
- Full Text
- View/download PDF